Between 95.2% and 97.4% of patients receiving Cetrotide has no LH surge (the percentages were 98% and 97.2% for buserelin and triptorelin, respectively).
Cetrotide’ iga ravitud patsientidest 95, 2– 97, 4% - l ei tekkinud LH tõusu (busereliini ja triptoreliini vastavad näitajad olid 98% ja 97, 2%).